Zanidatamab, palbociclib and fulvestrant show positive results in treating HER2+/HR+ mBC

Toripalimab and metronomic chemotherapy show efficacy in treating in HER2-negative metastatic breast cancer

Adding nivolumab to R-GemOx shows enhanced efficacy in treating R/R large B-cell lymphoma

Beat AML master trial: A clinical trial for acute myeloid leukaemia

BrECADD combined with PET2-guided treatment sets a new benchmark for the treatment of newly diagnosed advanced-stage cHL

Ponatinib is superior to imatinib in combination with chemotherapy for newly diagnosed Ph+ ALL

Introducing oncology to undergraduate medical and allied health sciences students

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours

Cancer care in Needle Hospital, Hargeisa, Somaliland

First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/M cervical cancer

Trial investigates multiparametric prognostic score in early HR+/HER2- breast cancer

Chairperson: Evidence Communication